SEC-FDA agreement heightens focus on life science disclosure and governance risks
November 17, 2026
November 17, 2026
KANSAS CITY, Missouri, Nov. 17 [Category: BizInsurance] -- Lockton, an insurance broker, posted the following news:
* * *
SEC-FDA agreement heightens focus on life science disclosure and governance risks
*
Key takeaways:
* A memorandum of understanding between the SEC and FDA expands information sharing, potentially making inconsistencies between regulatory communications and investor disclosures easier to identify.
* . . .
* * *
SEC-FDA agreement heightens focus on life science disclosure and governance risks
*
Key takeaways:
* A memorandum of understanding between the SEC and FDA expands information sharing, potentially making inconsistencies between regulatory communications and investor disclosures easier to identify.
* . . .
